No Data
No Data
TD Cowen Maintains Ginkgo Bioworks(DNA.US) With Buy Rating, Raises Target Price to $16
Ginkgo Bioworks Price Target Raised to $16 From $10 at TD Cowen
Ginkgo Automation to Deploy Flexible Laboratory Automation System for Cutting-Edge Biofuels and Bioproducts Research at Great Lakes Bioenergy Research Center (GLBRC)
Moderna Spikes as Oracle's Larry Ellison Touts AI-driven MRNA Vaccines
SaponiQx, Probius, and Ginkgo Bioworks Unite to Revolutionize Vaccine Adjuvant Development
Government Contract Update: $54M Payment to GINKGO BIOWORKS, INC.